Mmbg Investment Advisors CO. significantly increased its stake in AbbVie Inc. by 88.9% in Q3, now owning 17,115 shares valued at $3.96 million. This increase follows AbbVie’s stronger-than-expected quarterly results, record net sales, and optimistic FY2026 EPS guidance. However, the company faces legal and policy uncertainties due to its lawsuit against HHS/CMS over Medicare drug price negotiations for Botox.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Mmbg Investment Advisors CO. Has $3.96 Million Holdings in AbbVie Inc. $ABBV
Mmbg Investment Advisors CO. significantly increased its stake in AbbVie Inc. by 88.9% in Q3, now owning 17,115 shares valued at $3.96 million. This increase follows AbbVie’s stronger-than-expected quarterly results, record net sales, and optimistic FY2026 EPS guidance. However, the company faces legal and policy uncertainties due to its lawsuit against HHS/CMS over Medicare drug price negotiations for Botox.